BVS
(NASDAQ)Bioventus Inc.
$14.38-- (--)
Loading... - Market loading
Bioventus (BVS) Stock Price & Financial Analysis
Bioventus Stock Price Chart
Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
Day's Range$14.20 - $14.41
52-Week High$15.89
52-Week Low$6.26
Open$14.33
Volume747.25K
Average Volume (3M)760.85K
Market Cap1.01B
Shares Outstanding70.01M
P/E Ratio (TTM)34.12
Price to Sales (P/S)1.69
Price to Book (P/B)5.14
EV/EBITDA11.69
Revenue (TTM)576.30M
Net Income (TTM)28.48M
Free Cash Flow (TTM)100.63M
EPS (TTM)$0.41
Profit Margin4.94%
Operating Margin10.64%
Return on Equity (ROE)15.08%
Debt to Equity1.44
50-Day MA$11.54
200-Day MA$9.26
52-Week Change93.31%
Annual Dividend$0.00
Dividend Yield0.00%
Payout Ratio0.00%
Day's Range$14.20 - $14.41
52-Week High$15.89
52-Week Low$6.26
Open$14.33
Volume747.25K
Average Volume (3M)760.85K
Market Cap1.01B
Shares Outstanding70.01M
P/E Ratio (TTM)34.12
Price to Sales (P/S)1.69
Price to Book (P/B)5.14
EV/EBITDA11.69
Revenue (TTM)576.30M
Net Income (TTM)28.48M
Free Cash Flow (TTM)100.63M
EPS (TTM)$0.41
Profit Margin4.94%
Operating Margin10.64%
Return on Equity (ROE)15.08%
Debt to Equity1.44
50-Day MA$11.54
200-Day MA$9.26
52-Week Change93.31%
Annual Dividend$0.00
Dividend Yield0.00%
Payout Ratio0.00%
Frequently Asked Questions About Bioventus
What is the current stock price for BVS?
As of the latest trading session, BVS stock trades at $14.38. The 52-week range is $6.26–$15.89, with a day range of $14.20–$14.41.
What is the P/E ratio for BVS?
Bioventus's trailing P/E ratio is 34.1, meaning investors pay $34.1 for every $1 of annual earnings. Bioventus operates in the Healthcare sector.
Does BVS pay dividends?
Bioventus does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.
What do analysts recommend for BVS?
Based on 1 analyst, the consensus for BVS is Buy.
What is the market cap of BVS?
Bioventus's market capitalization is $1.01B, classifying it as a small-cap company. Bioventus operates in the Healthcare sector within the Medical Devices industry.